No sperm in the ejaculate does not mean there are none in the body. Three surgical methods — and one fundamentally new perspective on male infertility.
Azoospermia — the complete absence of sperm in the ejaculate — affects approximately one percent of men in the general population, and between ten and fifteen percent of men presenting with infertility. Twenty years ago, this diagnosis effectively meant biological fatherhood with one's own genetic material was impossible. That is no longer the case. Surgical sperm retrieval methods — TESA, PESA and Micro-TESE — have changed the picture radically. But understanding which method is right for a specific man is impossible without first understanding why no sperm appears in the ejaculate.
The distinction is fundamental. Sperm may fail to reach the ejaculate for two entirely different reasons. The first is obstructive azoospermia: sperm is produced normally but cannot exit due to a blockage in the ducts. The second is non-obstructive azoospermia: the testes themselves either produce no sperm at all, or produce it in negligibly small quantities. This distinction determines everything — the choice of method and the prognosis.
In obstructive azoospermia, the testis produces sperm at normal or near-normal volumes. The problem is that the vas deferens or epididymis is blocked — due to a previous infection, congenital absence of the duct, prior surgery (vasectomy) or trauma. Sperm accumulates and degrades without reaching the ejaculate. For these men, surgical retrieval is relatively straightforward — technically speaking. Because the material is there; it simply needs to be extracted.
PESA — Percutaneous Epididymal Sperm Aspiration. A fine needle is inserted through the scrotal skin directly into the epididymis. The procedure takes a few minutes, performed under local anaesthesia or light sedation. The fluid obtained contains sperm, which is used immediately for fertilisation or frozen. PESA is minimally invasive — no incision, minimal discomfort, rapid recovery. For obstructive azoospermia it is often the first choice.
TESA — Testicular Sperm Aspiration. A needle is inserted directly into the testicular tissue and aspirates a small amount of tissue with fluid. Also minimally invasive, performed under anaesthesia. Used when PESA yields insufficient material or when the problem is located in the testis itself rather than the epididymis. Sperm retrieved via TESA is generally less mature than via PESA, since it has not completed maturation in the epididymis. For fertilisation this is not critical — fertilisation occurs via ICSI (intracytoplasmic sperm injection), in which a single sperm is injected directly into the egg.
Non-obstructive azoospermia is a fundamentally different situation. The ducts are fine, but the testis either has no spermatogenesis at all (aplastic form), or has it only in isolated, focal areas. A blind needle cannot find these focal areas. Micro-TESE was developed specifically for this scenario.
Micro-TESE — Microsurgical Testicular Sperm Extraction. The surgeon, working under an operating microscope at high magnification, opens the testis and methodically examines the seminiferous tubules for those that visually appear more dilated — a sign of active spermatogenesis. The identified tubules are carefully removed and passed to an embryologist, who searches under a microscope for live sperm within them.
The procedure takes two to four hours, requires general anaesthesia and a highly skilled surgeon with specialised equipment. Recovery takes several days. This is incomparably more complex than PESA or TESA — but for men with non-obstructive azoospermia, it is the only realistic chance of obtaining their own sperm. Success rates vary depending on the cause. With Klinefelter syndrome (XXY karyotype — one of the most common causes of non-obstructive azoospermia), sperm is found in approximately forty to sixty percent of cases. Across published series, the overall retrieval rate averages around forty to sixty percent. For a condition that was once considered an absolute barrier to genetic fatherhood, this is remarkable.
Regardless of the retrieval method, the sperm obtained is used in an IVF-ICSI protocol. Standard IVF — where sperm penetrate the egg independently — is generally not applied with surgically retrieved material, because there is always a limited quantity and each sperm is precious. If more sperm are obtained than needed for one cycle, the surplus is frozen. This is important: frozen material enables repeat IVF attempts without repeat surgery. Many clinics therefore deliberately separate the surgical retrieval from the IVF cycle: surgery and freezing first, then a planned IVF cycle.
None of these procedures are performed without prior investigation. The standard minimum includes:
AZF-region Y-chromosome deletions are worth understanding. AZFa and AZFb deletions almost always indicate complete absence of spermatogenesis, and Micro-TESE is not indicated. AZFc deletions are milder — sperm is found in approximately seventy percent of cases. A single genetic test can prevent an unnecessary operation. One important note for couples considering IVF: if a man carries an AZFc deletion, sons born with his sperm will inherit the same deletion and will likely face the same fertility challenges.
Azoospermia is often discovered unexpectedly — during routine pre-IVF investigation or when exploring options for co-parenting. For a man planning co-parenting, timely investigation either confirms that biological fatherhood is possible with surgical methods, or enables an informed decision about donor sperm. If a man with azoospermia wants to use his own genetic material in co-parenting, the logistics become more complex: agreement is needed with a clinic that will perform the surgical retrieval, freeze the material and then conduct IVF-ICSI with the female co-parent's eggs (or donor eggs). This is entirely feasible — but requires additional planning and, as a rule, choosing a clinic with experience in such protocols.
Azoospermia today is not a sentence against biological fatherhood. Three surgical retrieval methods — PESA, TESA and Micro-TESE — are applied depending on the cause and form of the condition. In obstructive azoospermia, PESA and TESA yield high success rates. In non-obstructive azoospermia, Micro-TESE remains a complex but real possibility for roughly half of patients. The key is correct prior investigation — including genetic testing — which makes it possible to choose the method and assess the outlook before the first procedure.